Age, y |
1.50 |
0.05-26.25 |
Weight at transplantation, kg |
12.0 |
2.74-73.10 |
Cryopreserved TNCs, × 107/kg |
9.73 |
2.24-50.37 |
Reinfused TNCs, × 107/kg |
7.57 |
1.49-32.40 |
Postthaw reinfused CD34+, × 105/kg |
2.14 |
0.42-104.75 |
Postthaw reinfused CD3+, × 106/kg |
14.15 |
3.26-100.56 |
Total postthaw reinfused CFUs, × 104/kg |
5.74 |
0.00-105.30 |
Primary disease |
N |
% |
Hurler syndrome |
45 |
28.3 |
Krabbe disease |
36 |
22.6 |
Sanfilippo syndrome |
19 |
11.9 |
Metachromatic leukodystrophy |
15 |
9.4 |
Adrenoleukodystrophy (ALD) |
13 |
8.2 |
Tay Sachs disease |
9 |
5.7 |
Hunter syndrome |
6 |
3.8 |
Lesch-Nyhan disease |
4 |
2.5 |
Sandhoff disease |
3 |
1.9 |
Hurler Scheie |
2 |
1.3 |
Niemann-Pick B |
2 |
1.3 |
Alpha mannosidosis |
1 |
0.6 |
GM1 gangliosidosis |
1 |
0.6 |
I-cell disease |
1 |
0.6 |
Maroteaux-Lamy syndrome |
1 |
0.6 |
Pelizaeus-Merzbacher disease |
1 |
0.6 |
Performance status < 80 |
66 |
41.5 |
Recipient CMV serology negative |
128 |
80.5 |
HLA match |
|
|
6/6 |
7 |
4.4 |
5/6 |
75 |
47.2 |
4/6 |
73 |
45.9 |
3/6 |
4 |
2.5 |
ABO matching mismatched |
71 |
44.7 |
Recipient sex female |
62 |
39.0 |
Unit sex female |
80 |
50.3 |
Sex matching (recipient/unit) |
|
|
F/F |
32 |
20.1 |
F/M |
30 |
18.9 |
M/M |
49 |
30.8 |
M/F |
48 |
30.2 |
Recipient race white |
133 |
83.7 |
Donor race white |
126 |
83.4 |
Race matching (recipient/unit) |
|
|
White/white |
113 |
74.8 |
White/other |
15 |
9.9 |
Other/other |
10 |
6.6 |
Other/white |
13 |
8.6 |